Strategic Funding. Tailored Solutions. Real Impact.

Explore how Concept to Market LLC helps life science innovators secure non-dilutive funding and navigate the path from discovery to commercialization—without giving up equity.

Concept to Market LLC is a premier advisory firm dedicated to helping life science innovators secure non-dilutive funding to bring transformative pharmaceutical, biotech, and medical technologies to market. With over 25 years of experience navigating government grants, public-sector contracts, and foundation-based support, we provide strategic guidance that empowers organizations to grow without giving up equity. Our clients include startups, clinical-stage ventures, established biopharmaceutical companies, academic institutions, non-profits, and healthcare investors.

Whether you’re pursuing your first NIH grant, preparing for BARDA engagement, or commercializing breakthrough research, our team delivers tailored, end-to-end support. From identifying the right funding opportunities to crafting compelling proposals and managing post-award compliance, we will guide your innovation journey to be both financially sustainable and strategically sound.

Barbara Solow, PH.D., Managing Partner

With over 25 years of experience in pharmaceutical, biotechnology, and medical device development, Barbara Solow is a recognized leader in non-dilutive funding strategy and healthcare innovation. As the founder of Concept to Market LLC, she has guided organizations of all sizes—from startups to global contractors—through the complexities of product commercialization, regulatory strategy, and public-sector funding.

Dr. Solow’s leadership is defined by her ability to translate complex funding landscapes and regulatory frameworks into actionable strategies that drive innovation and financial sustainability. She has led programs valued at over $1 billion for U.S. government agencies and has helped clients secure more than $3 billion+ in non-dilutive funding. As a trusted advisor at the intersection of science, policy, and commercialization, she ensures Concept to Market clients are positioned for long-term success—advancing breakthrough healthcare solutions without compromising equity.

Brian Penny, Managing Partner

With over 30 years of experience in both government and commercial sectors, Brian Penny is a strategic leader with deep expertise in corporate financing, government contracting, and healthcare innovation. As managing partner of Concept to Market LLC, he brings a results-driven approach to securing non-dilutive funding and building sustainable growth strategies for life science organizations.

Mr. Penny’s leadership is defined by his ability to translate complex regulatory and contractual frameworks into actionable strategies that drive growth and compliance. His deep knowledge of FAR and DFAR, combined with a proven track record in securing over $3 billion+ in funding, positions him as a trusted advisor to organizations navigating the intersection of innovation and government engagement. With a focus on strategic execution, operational excellence, and financial stewardship, he ensures Concept to Market clients achieve sustainable success without compromising equity.

Robert Hopkins, MD, MPH and TM, Senior Medical Advisor

With over 25 years of experience in infectious diseases, regulatory affairs, and clinical development, Dr. Robert Hopkins is a seasoned leader in advancing medical products from concept to licensure. His career spans pivotal roles at the FDA’s Center for Drug Evaluation and Research (CDER), as well as leadership positions at Merck, DynPort Vaccine Company, Emergent BioSolutions, and Aeras. Most recently, he served as Chief Medical Officer at Adaptive Phage Therapeutics and Ocugen.

Dr. Hopkins’s expertise lies in translating complex clinical and regulatory requirements into actionable development strategies. He has successfully guided multiple products into the U.S. Strategic National Stockpile and served as a Senior Medical Advisor to BARDA. His deep understanding of infectious disease therapeutics and government engagement ensures Concept to Market clients are equipped to navigate high-stakes development with confidence and precision.

Patrick D. Saam, Senior Financial Advisor

With over 25 years of experience in finance, accounting, and biotech operations, Patrick Saam brings a results-oriented approach to financial strategy and compliance in life sciences. His background includes extensive work in government accounting, biotech manufacturing, forecasting, and process optimization.
Mr. Saam’s leadership is defined by his ability to drive operational efficiency and financial clarity across complex organizations. He has led initiatives in process reengineering, strategic planning, and continuous improvement, consistently exceeding financial goals. At Concept to Market, he ensures clients are equipped with the financial infrastructure and insight needed to scale sustainably and remain audit-ready in highly regulated environments.